Table 3.
Comparison of the clinical characteristics between the infection group and non-infection group
| Infection (n = 37) | Non-infection (n = 570) | p-value | |
|---|---|---|---|
| Age over 65 years old, n (%) | 19 (51.4) | 319 (55.8) | 0.613 |
| Male Sex, n (%) | 20 (54.1) | 315 (55.3) | 1 |
| Silver-mixed port, n (%) | 6 (16.2) | 197 (34.6) | 0.0294* |
| Steroids, n (%) | 3 (8.1) | 14 (2.5) | 0.0784 |
| Diabetes Mellitus, n (%) | 3 (8.11) | 98 (17.1) | 0.177 |
| Alb (g/dl), Average ± SD | 3.4 ± 0.7 | 3.2 ± 0.7 | 0.153 |
| CRP (mg/dl), Average ± SD | 2.2 ± 4.3 | 2.0 ± 2.5 | 0.729 |
| Nutrition, n (%) | 15 (40.5) | 155 (27.2) | 0.0898 |
| ANC < 1500 cells/mm3, n (%) | 5 (13.5) | 31 (5.4) | 0.0599 |
| Underlying Disease | |||
| Colon and Intestinal Cancer, n (%) | 9 (24.3) | 160 (28.1) | 0.708 |
| Head and Neck Cancer, n (%) | 4 (10.8) | 39 (6.8) | 0.323 |
| Hepatobiliary Pancreatic Cancer, n (%) | 6 (16.2) | 153 (26.8) | 0.18 |
| Gastric Cancer, n (%) | 2 (5.4) | 30 (5.3) | 1 |
| Esophageal Cancer, n (%) | 0 (0) | 24 (4.2) | 0.389 |
| Breast Cancer, n (%) | 2 (5.4) | 17 (3.0) | 0.324 |
| Gynecologic Cancer, n (%) | 5 (13.5) | 62 (10.9) | 0.588 |
| Hematological Disease, n (%) | 1 (2.7) | 28 (4.9) | 1 |
| Lung Cancer, n (%) | 2 (5.4) | 18 (3.2) | 0.346 |
| Urothelial and Kidney Cancer, n (%) | 0 (0) | 7 (1.2) | 1 |
| Primary Brain Tumor, n (%) | 1 (2.7) | 6 (1.1) | 0.357 |
| Soft Tissue and Bone Malignancies, n (%) | 0 (0) | 4 (0.7) | 1 |
| Other Benign Disease, n (%) | 4 (10.8) | 23 (4.2) | 0.0746 |
| Procedure Details | |||
| Right Sided Implantation, n (%) | 34 (91.9) | 527 (92.7) | 0.754 |
| Length of Catheter (cm), Average ± SD | 18.0 ± 3.0 | 17.2 ± 3.3 | 0.155 |
| Preoperative Antibiotics, n (%) | 18 (48.6) | 219 (38.4) | 0.227 |
SD Standard Deviation, Alb Albumin, CRP C-reactive protein, ANC Absolute neutrophil count
*Statistically significant